Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Bhatwadekar: A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopath.... (0.11 sec) 

A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in …


A Bhatwadekar, JV Glenn, JL Figarola, S Scott … - British Medical Journal, 2008 - bjo.bmj.com
Methods: Streptozotocin-induced diabetic Sprague–Dawley rats were treated with
LR-90 (50 mg/l in drinking water) for up to 32 weeks. At the end of the study,
eyes were enucleated and subjected to trypsin digestion and staining with ...
Cited by 4 - Related articles - BL Direct - All 3 versions

Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced …


S Yamagishi, K Nakamura, T Matsui, H Inoue, … - Medical hypotheses, 2007 - Elsevier
The pathological role of the non-enzymatic modification of proteins by reducing
sugars has become increasingly evident in various disorders. It is now well
established that early glycation products undergo progressive modification ...
Cited by 5 - Related articles - All 25 versions

[CITATION] Fluocinolone Acetonide Uveitis Study Group. Fluocinolone acetonide intravitreal implant for …


G Jaffe - Invest Ophthalmol Vis Sci, 2004
Cited by 2 - Related articles

Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end …


S Yamagishi, K Nakamura, H Inoue - Medical hypotheses, 2005 - Elsevier
Reducing sugars can react non-enzymatically with amino groups of protein to form
Amadori products. These early glycation products undergo further complex
reaction such as rearrangement, dehydration, and condensation to become ...
Cited by 3 - Related articles - All 20 versions

[CITATION] iCo-007, a VEGF “+” agent for the potential treatment of diabetic macular edema and …


P Hnik, JG Clement, SJ Ono, SP Henry - Association for Research in Vision and Ophthalmology …, 2008
Cited by 2 - Related articles

[CITATION] RACE Study Group. The RACE Study: bevasiranib for the treatment of diabetic macular …


JL Prenner - Association for Research in Vision and Ophthalmology …, 2007
Cited by 2 - Related articles

[CITATION] A Randomized Dose-Escalation Trial of Locally-Administered Sirolimus to Treat Diabetic …


MS Blumenkranz, PU Dugel, WA Solley… - 2008 Annual Meeting of the Association of Reseach in …, 2008
Cited by 2 - Related articles

Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with …


MS Wu, JT Liang, YD Lin, ET Wu, YZ Tseng, … - British Journal of Pharmacology, 2008 - pubmedcentral.nih.gov
After induction of type 2 diabetes, rats received daily injections of AG (50 mg
kg −1 , ip) for 8 weeks and were compared with age-matched, untreated,
diabetic controls. Left ventricular (LV) pressure and ascending aortic flow ...
Cited by 2 - Related articles - BL Direct - All 3 versions

Intravitreal steroids for macular edema: the past, the present, and the future


MA Cunningham, JL Edelman, S Kaushal - Survey of Ophthalmology, 2008 - Elsevier
Macular edema, a condition usually associated with an underlying disease
process, is a common cause of severe visual loss. There have been a variety of
approaches to the treatment of macular edema; within the past few years, ...
Cited by 9 - Related articles - All 17 versions

A novel pleiotropic effect of atorvastatin on advanced glycation end product (AGE)-related …


S Yamagishi, K Nakamura, T Matsui, H Inoue - Medical hypotheses, 2007 - Elsevier
Reducing sugars can react non-enzymatically with the amino groups of proteins to
form reversible Schiff bases, and then Amadori products. These early glycation
products undergo further complex reactions such as rearrangement, ...
Cited by 3 - Related articles - All 31 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google